AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abeywardena, M. Y.
Right arrow Articles by Charnock, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abeywardena, M. Y.
Right arrow Articles by Charnock, J. S.
Agricola
Right arrow Articles by Abeywardena, M. Y.
Right arrow Articles by Charnock, J. S.

American Journal of Clinical Nutrition, Vol 53, 1039S-1041S, Copyright © 1991 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Changes in myocardial eicosanoid production following long-term dietary lipid supplementation in rats

MY Abeywardena, PL McLennan and JS Charnock
Division of Human Nutrition, CSIRO, South Australia.

Recent studies demonstrate a strong link between the type of fat consumed and arrhythmogenesis and implicate altered production of eicosanoids as a potential mechanism. Thus, in a preliminary study designed to evaluate this hypothesis, five dietary lipid supplements-- sunflower seed oil (SSO), chemically refined palm oil (PO I), physically refined palm oil (PO II), sheep fat (SF), and a 1:1 blend of SF and fish oil (SF-FO)--were compared for their effects on membrane- lipid composition and eicosanoid synthesis after a 12-mo pre-feeding period. Polyunsaturated fatty acids (PUFAs) of the myocardium showed significant alterations in response to dietary lipid treatment. Nevertheless, prostacyclin production was unaffected whereas both SF-FO and POI diets caused a significant inhibition of myocardial thromboxane A2 (TXA2). It is speculated that n-3 (omega-3) PUFAs may act as specific inhibitors of TXA2 synthetase whereas the PO I effect is unlikely to be mediated via fatty acids. These preliminary data are worthy of further investigation.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The American Society for Nutrition